← Feed

DeLuca Richard R.

SEC Form 4 insider
EVP&Pres, Merck Animal Heallth · Merck & Co., Inc. ($MRK)
2 theses · first seen Aug 11, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d22150%+0.5%+0.5%
3d2200%+2.6%+2.6%
1w2200%+9.2%+9.2%
1m2200%+10.5%+10.5%
3m000———
6m000———
1y000———

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$MRKSEC Form 4bearish
DeLuca Richard R. · EVP&Pres, Merck Animal Heallth at Merck & Co., Inc. · 49d ago1 prior · awaiting results
Sold 45,320 @ $131.12 avg · $5,942,369 · 2026-08-10

Form 4: DeLuca Richard R. sold MRK

DeLuca Richard R. (EVP&Pres, Merck Animal Heallth at Merck & Co., Inc.) reported an open-market sale of 45,320 shares of MRK at an average $131.12, roughly $5,942,369, in a Form 4 filed 2026-08-12.

At post $132.92Now $146.87+10.5% since postedas of Sep 18, 4:30 PM ET
1d+1.4%
3d+2.2%
1w+14.5%
1m+8.3%
3m—
6m—
1y—
View filing on SEC.gov →
$MRKSEC Form 4bearish
DeLuca Richard R. · EVP&Pres, Merck Animal Heallth at Merck & Co., Inc. · 51d ago1 prior · awaiting results
Sold 6,050 @ $130.38 avg · $788,773 · 2026-08-06

Form 4: DeLuca Richard R. sold MRK

DeLuca Richard R. (EVP&Pres, Merck Animal Heallth at Merck & Co., Inc.) reported an open-market sale of 6,050 shares of MRK at an average $130.38, roughly $788,773, in a Form 4 filed 2026-08-10.

At post $130.92Now $146.87+12.2% since postedas of Sep 18, 4:30 PM ET
1d-0.4%
3d+2.9%
1w+3.9%
1m+12.7%
3m—
6m—
1y—
View filing on SEC.gov →

End of results.